Beneficial effects of perhexiline in cardiovascular disease states /:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Weitere Verfasser: | , |
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
New York :
Nova Biomedical/Nova Science Publishers,
©2010.
|
| Schriftenreihe: | Cardiology research and clinical developments series.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | 1 online resource (viii, 43 pages) |
| Bibliographie: | Includes bibliographical references (pages 31-38) and index. |
| ISBN: | 9781617286308 1617286303 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn698081866 | ||
| 003 | OCoLC | ||
| 005 | 20241004212047.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 110124s2010 nyu ob 001 0 eng d | ||
| 010 | |z 2010016659 | ||
| 040 | |a N$T |b eng |e pn |c N$T |d OCLCQ |d YDXCP |d OCLCQ |d E7B |d OCLCQ |d NLGGC |d EBLCP |d OCLCQ |d AZK |d YDX |d MERUC |d AGLDB |d OCLCO |d MOR |d PIFAG |d OCLCO |d ZCU |d OCLCO |d OCLCQ |d OCLCO |d OCLCA |d U3W |d OCLCA |d OCLCF |d OCLCO |d STF |d VNS |d WRM |d OCLCQ |d VTS |d NRAMU |d ICG |d OCLCQ |d VT2 |d TOF |d OCLCO |d OCLCQ |d WYU |d OCLCO |d OCLCA |d DKC |d AU@ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCA |d OCLCQ |d OCLCA |d UKCRE |d AJS |d OCLCO |d OCLCQ |d OCLCO |d OCLCQ |d OCLCL | ||
| 019 | |a 961569430 |a 962650743 |a 988499573 |a 991918688 |a 1037910426 |a 1038700245 |a 1045504824 |a 1153514852 | ||
| 020 | |a 9781617286308 |q (electronic bk.) | ||
| 020 | |a 1617286303 |q (electronic bk.) | ||
| 020 | |z 9781616689773 | ||
| 020 | |z 1616689773 | ||
| 035 | |a (OCoLC)698081866 |z (OCoLC)961569430 |z (OCoLC)962650743 |z (OCoLC)988499573 |z (OCoLC)991918688 |z (OCoLC)1037910426 |z (OCoLC)1038700245 |z (OCoLC)1045504824 |z (OCoLC)1153514852 | ||
| 050 | 4 | |a RM345 |b .C55 2010eb | |
| 060 | 4 | |a QV 150 |b C541b 2009 | |
| 072 | 7 | |a HEA |x 039080 |2 bisacsh | |
| 072 | 7 | |a MED |x 010000 |2 bisacsh | |
| 082 | 7 | |a 616.1/22061 |2 22 | |
| 049 | |a MAIN | ||
| 100 | 1 | |a Chirkov, Yuliy Y. | |
| 245 | 1 | 0 | |a Beneficial effects of perhexiline in cardiovascular disease states / |c Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz. |
| 260 | |a New York : |b Nova Biomedical/Nova Science Publishers, |c ©2010. | ||
| 300 | |a 1 online resource (viii, 43 pages) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 490 | 1 | |a Cardiology research and clinical developments | |
| 504 | |a Includes bibliographical references (pages 31-38) and index. | ||
| 505 | 0 | |a Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives. | |
| 588 | 0 | |a Print version record. | |
| 650 | 0 | |a Perhexiline |x Therapeutic use. | |
| 650 | 0 | |a Angina pectoris |x Chemotherapy. |0 http://id.loc.gov/authorities/subjects/sh85005023 | |
| 650 | 0 | |a Cardiovascular agents. |0 http://id.loc.gov/authorities/subjects/sh85020222 | |
| 650 | 1 | 2 | |a Perhexiline |x therapeutic use |
| 650 | 2 | 2 | |a Cardiovascular Agents |x therapeutic use |
| 650 | 2 | 2 | |a Cardiovascular Diseases |x drug therapy |
| 650 | 2 | 2 | |a Perhexiline |x adverse effects |
| 650 | 2 | 2 | |a Perhexiline |x pharmacology |
| 650 | 2 | |a Cardiovascular Agents |0 https://id.nlm.nih.gov/mesh/D002317 | |
| 650 | 6 | |a Perhexiline |x Emploi en thérapeutique. | |
| 650 | 6 | |a Angine de poitrine |x Chimiothérapie. | |
| 650 | 6 | |a Agents cardiovasculaires. | |
| 650 | 7 | |a HEALTH & FITNESS |x Diseases |x Heart. |2 bisacsh | |
| 650 | 7 | |a MEDICAL |x Cardiology. |2 bisacsh | |
| 650 | 7 | |a Angina pectoris |x Chemotherapy |2 fast | |
| 650 | 7 | |a Cardiovascular agents |2 fast | |
| 700 | 1 | |a Sverdlov, Aaron L. | |
| 700 | 1 | |a Horowitz, John D. | |
| 758 | |i has work: |a Beneficial effects of perhexiline in cardiovascular disease states (Text) |1 https://id.oclc.org/worldcat/entity/E39PCGhyKhrqdxqv6MQ8FcjkCP |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |a Chirkov, Yuliy Y. |t Beneficial effects of perhexiline in cardiovascular disease states. |d New York : Nova Biomedical/Nova Science Publishers, 2010 |z 9781616689773 |w (DLC) 2010016659 |w (OCoLC)610206324 |
| 830 | 0 | |a Cardiology research and clinical developments series. |0 http://id.loc.gov/authorities/names/no2009082882 | |
| 856 | 4 | 0 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=346590 |3 Volltext |
| 938 | |a ProQuest Ebook Central |b EBLB |n EBL3020732 | ||
| 938 | |a ebrary |b EBRY |n ebr10680870 | ||
| 938 | |a EBSCOhost |b EBSC |n 346590 | ||
| 938 | |a YBP Library Services |b YANK |n 3609008 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
| 049 | |a DE-863 | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn698081866 |
|---|---|
| _version_ | 1816881749609676800 |
| adam_text | |
| any_adam_object | |
| author | Chirkov, Yuliy Y. |
| author2 | Sverdlov, Aaron L. Horowitz, John D. |
| author2_role | |
| author2_variant | a l s al als j d h jd jdh |
| author_facet | Chirkov, Yuliy Y. Sverdlov, Aaron L. Horowitz, John D. |
| author_role | |
| author_sort | Chirkov, Yuliy Y. |
| author_variant | y y c yy yyc |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | RM345 |
| callnumber-raw | RM345 .C55 2010eb |
| callnumber-search | RM345 .C55 2010eb |
| callnumber-sort | RM 3345 C55 42010EB |
| callnumber-subject | RM - Therapeutics and Pharmacology |
| collection | ZDB-4-EBA |
| contents | Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives. |
| ctrlnum | (OCoLC)698081866 |
| dewey-full | 616.1/22061 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.1/22061 |
| dewey-search | 616.1/22061 |
| dewey-sort | 3616.1 522061 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03908cam a2200721 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn698081866</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20241004212047.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cnu---unuuu</controlfield><controlfield tag="008">110124s2010 nyu ob 001 0 eng d</controlfield><datafield tag="010" ind1=" " ind2=" "><subfield code="z"> 2010016659</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">N$T</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">N$T</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">YDXCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">E7B</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">NLGGC</subfield><subfield code="d">EBLCP</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AZK</subfield><subfield code="d">YDX</subfield><subfield code="d">MERUC</subfield><subfield code="d">AGLDB</subfield><subfield code="d">OCLCO</subfield><subfield code="d">MOR</subfield><subfield code="d">PIFAG</subfield><subfield code="d">OCLCO</subfield><subfield code="d">ZCU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">U3W</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">STF</subfield><subfield code="d">VNS</subfield><subfield code="d">WRM</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VTS</subfield><subfield code="d">NRAMU</subfield><subfield code="d">ICG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VT2</subfield><subfield code="d">TOF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">WYU</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">DKC</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKCRE</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">961569430</subfield><subfield code="a">962650743</subfield><subfield code="a">988499573</subfield><subfield code="a">991918688</subfield><subfield code="a">1037910426</subfield><subfield code="a">1038700245</subfield><subfield code="a">1045504824</subfield><subfield code="a">1153514852</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781617286308</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1617286303</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">9781616689773</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">1616689773</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)698081866</subfield><subfield code="z">(OCoLC)961569430</subfield><subfield code="z">(OCoLC)962650743</subfield><subfield code="z">(OCoLC)988499573</subfield><subfield code="z">(OCoLC)991918688</subfield><subfield code="z">(OCoLC)1037910426</subfield><subfield code="z">(OCoLC)1038700245</subfield><subfield code="z">(OCoLC)1045504824</subfield><subfield code="z">(OCoLC)1153514852</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">RM345</subfield><subfield code="b">.C55 2010eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QV 150</subfield><subfield code="b">C541b 2009</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">HEA</subfield><subfield code="x">039080</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">010000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">616.1/22061</subfield><subfield code="2">22</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chirkov, Yuliy Y.</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Beneficial effects of perhexiline in cardiovascular disease states /</subfield><subfield code="c">Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">New York :</subfield><subfield code="b">Nova Biomedical/Nova Science Publishers,</subfield><subfield code="c">©2010.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (viii, 43 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cardiology research and clinical developments</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 31-38) and index.</subfield></datafield><datafield tag="505" ind1="0" ind2=" "><subfield code="a">Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives.</subfield></datafield><datafield tag="588" ind1="0" ind2=" "><subfield code="a">Print version record.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Perhexiline</subfield><subfield code="x">Therapeutic use.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Angina pectoris</subfield><subfield code="x">Chemotherapy.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85005023</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Cardiovascular agents.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85020222</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Perhexiline</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Cardiovascular Agents</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Cardiovascular Diseases</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Perhexiline</subfield><subfield code="x">adverse effects</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Perhexiline</subfield><subfield code="x">pharmacology</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Cardiovascular Agents</subfield><subfield code="0">https://id.nlm.nih.gov/mesh/D002317</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Perhexiline</subfield><subfield code="x">Emploi en thérapeutique.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Angine de poitrine</subfield><subfield code="x">Chimiothérapie.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Agents cardiovasculaires.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">HEALTH & FITNESS</subfield><subfield code="x">Diseases</subfield><subfield code="x">Heart.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Cardiology.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Angina pectoris</subfield><subfield code="x">Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cardiovascular agents</subfield><subfield code="2">fast</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sverdlov, Aaron L.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Horowitz, John D.</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Beneficial effects of perhexiline in cardiovascular disease states (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCGhyKhrqdxqv6MQ8FcjkCP</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="a">Chirkov, Yuliy Y.</subfield><subfield code="t">Beneficial effects of perhexiline in cardiovascular disease states.</subfield><subfield code="d">New York : Nova Biomedical/Nova Science Publishers, 2010</subfield><subfield code="z">9781616689773</subfield><subfield code="w">(DLC) 2010016659</subfield><subfield code="w">(OCoLC)610206324</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cardiology research and clinical developments series.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2009082882</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=346590</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest Ebook Central</subfield><subfield code="b">EBLB</subfield><subfield code="n">EBL3020732</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10680870</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">346590</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">3609008</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-863</subfield></datafield></record></collection> |
| id | ZDB-4-EBA-ocn698081866 |
| illustrated | Not Illustrated |
| indexdate | 2024-11-27T13:17:40Z |
| institution | BVB |
| isbn | 9781617286308 1617286303 |
| language | English |
| oclc_num | 698081866 |
| open_access_boolean | |
| owner | MAIN DE-863 DE-BY-FWS |
| owner_facet | MAIN DE-863 DE-BY-FWS |
| physical | 1 online resource (viii, 43 pages) |
| psigel | ZDB-4-EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Nova Biomedical/Nova Science Publishers, |
| record_format | marc |
| series | Cardiology research and clinical developments series. |
| series2 | Cardiology research and clinical developments |
| spelling | Chirkov, Yuliy Y. Beneficial effects of perhexiline in cardiovascular disease states / Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz. New York : Nova Biomedical/Nova Science Publishers, ©2010. 1 online resource (viii, 43 pages) text txt rdacontent computer c rdamedia online resource cr rdacarrier Cardiology research and clinical developments Includes bibliographical references (pages 31-38) and index. Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives. Print version record. Perhexiline Therapeutic use. Angina pectoris Chemotherapy. http://id.loc.gov/authorities/subjects/sh85005023 Cardiovascular agents. http://id.loc.gov/authorities/subjects/sh85020222 Perhexiline therapeutic use Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Perhexiline adverse effects Perhexiline pharmacology Cardiovascular Agents https://id.nlm.nih.gov/mesh/D002317 Perhexiline Emploi en thérapeutique. Angine de poitrine Chimiothérapie. Agents cardiovasculaires. HEALTH & FITNESS Diseases Heart. bisacsh MEDICAL Cardiology. bisacsh Angina pectoris Chemotherapy fast Cardiovascular agents fast Sverdlov, Aaron L. Horowitz, John D. has work: Beneficial effects of perhexiline in cardiovascular disease states (Text) https://id.oclc.org/worldcat/entity/E39PCGhyKhrqdxqv6MQ8FcjkCP https://id.oclc.org/worldcat/ontology/hasWork Print version: Chirkov, Yuliy Y. Beneficial effects of perhexiline in cardiovascular disease states. New York : Nova Biomedical/Nova Science Publishers, 2010 9781616689773 (DLC) 2010016659 (OCoLC)610206324 Cardiology research and clinical developments series. http://id.loc.gov/authorities/names/no2009082882 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=346590 Volltext |
| spellingShingle | Chirkov, Yuliy Y. Beneficial effects of perhexiline in cardiovascular disease states / Cardiology research and clinical developments series. Clinical applications of perhexiline -- Pharmacokinetics and toxicity of perhexiline -- Pharmacology of perhexiline -- Conclusion and future perspectives. Perhexiline Therapeutic use. Angina pectoris Chemotherapy. http://id.loc.gov/authorities/subjects/sh85005023 Cardiovascular agents. http://id.loc.gov/authorities/subjects/sh85020222 Perhexiline therapeutic use Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Perhexiline adverse effects Perhexiline pharmacology Cardiovascular Agents https://id.nlm.nih.gov/mesh/D002317 Perhexiline Emploi en thérapeutique. Angine de poitrine Chimiothérapie. Agents cardiovasculaires. HEALTH & FITNESS Diseases Heart. bisacsh MEDICAL Cardiology. bisacsh Angina pectoris Chemotherapy fast Cardiovascular agents fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85005023 http://id.loc.gov/authorities/subjects/sh85020222 https://id.nlm.nih.gov/mesh/D002317 |
| title | Beneficial effects of perhexiline in cardiovascular disease states / |
| title_auth | Beneficial effects of perhexiline in cardiovascular disease states / |
| title_exact_search | Beneficial effects of perhexiline in cardiovascular disease states / |
| title_full | Beneficial effects of perhexiline in cardiovascular disease states / Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz. |
| title_fullStr | Beneficial effects of perhexiline in cardiovascular disease states / Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz. |
| title_full_unstemmed | Beneficial effects of perhexiline in cardiovascular disease states / Yuliy Y. Chirkov, Aaron L. Sverdlov, and John D. Horowitz. |
| title_short | Beneficial effects of perhexiline in cardiovascular disease states / |
| title_sort | beneficial effects of perhexiline in cardiovascular disease states |
| topic | Perhexiline Therapeutic use. Angina pectoris Chemotherapy. http://id.loc.gov/authorities/subjects/sh85005023 Cardiovascular agents. http://id.loc.gov/authorities/subjects/sh85020222 Perhexiline therapeutic use Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Perhexiline adverse effects Perhexiline pharmacology Cardiovascular Agents https://id.nlm.nih.gov/mesh/D002317 Perhexiline Emploi en thérapeutique. Angine de poitrine Chimiothérapie. Agents cardiovasculaires. HEALTH & FITNESS Diseases Heart. bisacsh MEDICAL Cardiology. bisacsh Angina pectoris Chemotherapy fast Cardiovascular agents fast |
| topic_facet | Perhexiline Therapeutic use. Angina pectoris Chemotherapy. Cardiovascular agents. Perhexiline therapeutic use Cardiovascular Agents therapeutic use Cardiovascular Diseases drug therapy Perhexiline adverse effects Perhexiline pharmacology Cardiovascular Agents Perhexiline Emploi en thérapeutique. Angine de poitrine Chimiothérapie. Agents cardiovasculaires. HEALTH & FITNESS Diseases Heart. MEDICAL Cardiology. Angina pectoris Chemotherapy Cardiovascular agents |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=346590 |
| work_keys_str_mv | AT chirkovyuliyy beneficialeffectsofperhexilineincardiovasculardiseasestates AT sverdlovaaronl beneficialeffectsofperhexilineincardiovasculardiseasestates AT horowitzjohnd beneficialeffectsofperhexilineincardiovasculardiseasestates |